Introduction Radiotherapy planning systems require many percentage depth dose (PDD) and profile measurements and there are various dosimeters that can be used to obtain these scans. As dose perturbation is particularly troublesome in smaller photon fields, using a low-perturbation, unshielded electron field diode (EFD) in these fields is of interest. The aim of this work was to investigate the ...

Introduction: The utilization of high-energy photons in the medical linear accelerator can lead to photoneutron production. This study aimed to evaluate the effect of the physical components of the head, including flattening filter (FF) andmultileaf collimator (MLC), as well as the dependence of therapeutic field size on the photoneutron spectrum, dose, and flux. <str...

We consider fitting the so-called Emax model to continuous response data from clinical trials designed to investigate the dose-response relationship for an experimental compound. When there is insufficient information in the data to estimate all of the parameters because of the high dose asymptote being ill defined, maximum likelihood estimation fails to converge. We explore the use of either b...

OBJECTIVE Evaluate the pharmacokinetics (PK), safety, and tolerability of single doses of once-daily USL255, Qudexy XR (topiramate) extended-release capsules, over a wide dosing range. METHODS Two single-dose, phase I studies in healthy adults were used to evaluate the PK profile and maximum tolerated dose (MTD) of USL255 from 25-1,400 mg. Standard PK parameters assessed included area under t...

9cUAB30 is a synthetic analog of 9-cis-retinoic acid with chemopreventive activity in cell lines and in animal models. The purpose of this first-in-human evaluation of 9cUAB30 was to evaluate the single-dose pharmacokinetic profile and toxicity of the compound in healthy volunteers at 3 dose levels. This study enrolled 14 patients to receive a single dose of 5, 10, or 20 mg of 9cUAB30. Plasma a...

Abstract Background Enoxaparin 0.75 mg/kg, with either a staged-dose regimen (0.5+0.25 mg/dl) or single-dose (0.75 achieves target anticoagulation for 90 min in patients undergoing percutaneous coronary intervention (PCI). In prolonged procedures (&amp;gt;90 min), supplementary-dose enoxaparin (0.375 mg/kg) needs to be given at maintain additional min. However, the actual anticoagulant profile ...

introduction the gamma knife system is designed solely for non-invasive treatment of brain disorders, and it benefits from stereotactic surgical techniques. dose calculations required in the system are performed by gammaplan code; in this code, brain tissue is considered uniform. in the present study, we evaluated the effect of gamma knife system on the obtained dose through simulating a real h...

Purpose: To determine the recommended phase II dose and evaluate the safety and toxicity profile and pharmacokinetic (PK) and pharmacodynamic (PD) effects of BNC105P, an inhibitor of tubulin polymerization that has vascular disrupting and antiproliferative effects. Experimental Design: BNC105P was administered as a 10-minute infusion on days 1 and 8 of a 21-day cycle in a first-in-human phase I...